{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:07:40Z","timestamp":1769105260175,"version":"3.49.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020717","name":"Center for High Performance Computing, Shanghai Jiao Tong University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32171246"],"award-info":[{"award-number":["32171246"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ijbiomac.2026.150222","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:20:38Z","timestamp":1768350038000},"page":"150222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Differential conformational selections of three therapeutic antibodies binding to polymorphic A\u03b2 oligomers"],"prefix":"10.1016","volume":"341","author":[{"given":"Honglin","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganggang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Buyong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.150222_bb0005","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3233\/JAD-170581","article-title":"The unexpected role of a\u03b2 monomers in the pathogenesis of Alzheimer\u2019s disease","volume":"62","author":"Tamagno","year":"2018","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0010","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.nbd.2009.08.007","article-title":"An amyloid-\u03b2 protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer\u2019s disease","volume":"36","author":"Lord","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0015","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.14336\/AD.2021.0529","article-title":"The cause of Alzheimer\u2019s disease: the theory of multipathology convergence to chronic neuronal stress","volume":"13","author":"Decourt","year":"2022","journal-title":"Aging Dis."},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0025","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"Medicine - the amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0030","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3233\/JAD-2006-9S338","article-title":"Segregation of a missense mutation in the amyloid \u03b2-protein precursor gene with familial Alzheimer\u2019s disease","volume":"9","author":"Goate","year":"2006","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0035","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1074\/jbc.R800018200","article-title":"Amyloid \u03b2-protein toxicity and the pathogenesis of Alzheimer disease","volume":"284","author":"Yankner","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0040","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/B978-0-12-385883-2.00012-6","article-title":"Alzheimer\u2019s disease and the amyloid \u03b2-protein","volume":"107","author":"Walsh","year":"2012","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0045","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nn.3028","article-title":"The toxic a\u03b2 oligomer and Alzheimer\u2019s disease: an emperor in need of clothes","volume":"15","author":"Benilova","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0050","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.neuro.26.010302.081142","article-title":"Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders","volume":"26","author":"Caughey","year":"2003","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid \u03b2-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0060","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrn2168","article-title":"Intracellular amyloid-\u03b2 in Alzheimer\u2019s disease","volume":"8","author":"LaFerla","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0065","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0166-2236(00)01749-5","article-title":"Targeting small A\u03b2 oligomers:: the solution to an Alzheimer\u2019s disease conundrum?","volume":"24","author":"Klein","year":"2001","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0070","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/15216540701283882","article-title":"Soluble protein oligomers as emerging toxins in Alzheimer\u2019s and other amyloid diseases","volume":"59","author":"Ferreira","year":"2007","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0075","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032014","article-title":"Large aggregates are the major soluble Abeta species in AD brain fractionated with density gradient ultracentrifugation","volume":"7","author":"Sehlin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0085","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s40265-021-01569-z","article-title":"Aducanumab: First Approval","volume":"81","author":"Dhillon","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0090","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40265-023-01851-2","article-title":"Lecanemab: first approval","volume":"83","author":"Hoy","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0095","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s40265-024-02087-4","article-title":"Donanemab: First Approval","volume":"84","author":"Kang","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0100","doi-asserted-by":"crossref","first-page":"197","DOI":"10.14283\/jpad.2022.30","article-title":"Two randomized phase 3 studies of Aducanumab in early Alzheimer\u2019s disease","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"J. Prev Alzheimers Dis."},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0105","first-page":"1631","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"Brenman","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0110","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"Jama-J Am Med Assoc"},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0115","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces a\u03b2 plaques in Alzheimer\u2019s disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0120","article-title":"Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-\u03b2","volume":"8","author":"Arndt","year":"2018","journal-title":"Sci Rep-Uk"},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0125","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/13543784.2023.2178414","article-title":"Lecanemab (BAN2401): an anti-beta-amyloid monoclonal antibody for the treatment of Alzheimer disease","volume":"32","author":"Vitek","year":"2023","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0130","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0135","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.neuron.2012.10.029","article-title":"A plaque-specific antibody clears existing beta-amyloid plaques in Alzheimer's disease mice","volume":"76","author":"Demattos","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/agt2.70078","article-title":"Solving the amyloid paradox: unveiling the complex pathogenicity of amyloid fibrils","volume":"6","author":"Sulatsky","year":"2025","journal-title":"Aggregate"},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0145","doi-asserted-by":"crossref","first-page":"18325","DOI":"10.1074\/jbc.M117.801514","article-title":"Mechanisms of recognition of amyloid-beta (Abeta) monomer, oligomer, and fibril by homologous antibodies","volume":"292","author":"Zhao","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0150","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/prot.25978","article-title":"From monomer to fibril: Abeta-amyloid binding to Aducanumab antibody studied by molecular dynamics simulation","volume":"88","author":"Frost","year":"2020","journal-title":"Proteins"},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0155","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0160","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1038\/s41467-023-38063-x","article-title":"Fast, accurate antibody structure prediction from deep learning on massive set of natural antibodies","volume":"14","author":"Ruffolo","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0165","doi-asserted-by":"crossref","DOI":"10.1038\/s41596-024-01011-0","article-title":"The HADDOCK2.4 web server for integrative modeling of biomolecular complexes","volume":"19","author":"Honorato","year":"2024","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.729513","article-title":"Structural biology in the clouds: the WeNMR-EOSC ecosystem","volume":"8","author":"Honorato","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4827","article-title":"Conformational features and interaction mechanisms of V H antibodies with \u03b2-hairpin CDR3: a case of Nb8-HigB2 interaction","volume":"32","author":"Yamamoto","year":"2023","journal-title":"Protein Sci."},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0180","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nmeth.4067","article-title":"CHARMM36m: an improved force field for folded and intrinsically disordered proteins","volume":"14","author":"Huang","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0185","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0190","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","article-title":"CHARMM-GUI input generator for NAMD, Gromacs, Amber, Openmm, and CHARMM\/OpenMM simulations using the CHARMM36 additive force field","volume":"12","author":"Lee","year":"2016","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0195","doi-asserted-by":"crossref","DOI":"10.1063\/5.0012280","article-title":"CHARMM-GUI supports the Amber force fields","volume":"153","author":"Lee","year":"2020","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0200","first-page":"704","article-title":"Very fast empirical prediction and rationalization of protein pK values, proteins-structure function and bioinformatics","volume":"61","author":"Li","year":"2005"},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0205","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jcc.20290","article-title":"The Amber biomolecular simulation programs","volume":"26","author":"Case","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0210","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/jcc.10272","article-title":"New analytic approximation to the standard molecular volume definition and its application to generalized born calculations","volume":"24","author":"Lee","year":"2003","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0215","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/jcc.21287","article-title":"CHARMM: the biomolecular simulation program","volume":"30","author":"Brooks","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0220","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1002\/jcc.23350","article-title":"CENCALC: a computational tool for conformational entropy calculations from molecular simulations","volume":"34","author":"Su\u00e1rez","year":"2013","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0225","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1021\/ma00137a013","article-title":"Evaluation of the configurational entropy for proteins: application to molecular dynamics simulations of an \u03b1-helix","volume":"17","author":"Levy","year":"1984","journal-title":"Macromolecules"},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0230","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1021\/ma50003a019","article-title":"Method for estimating the configurational entropy of macromolecules","volume":"14","author":"Karplus","year":"1981","journal-title":"Macromolecules"},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0235","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0240","doi-asserted-by":"crossref","first-page":"272a","DOI":"10.1016\/j.bpj.2021.11.1368","article-title":"MDAnalysis 2.0 and beyond: fast and interoperable, community driven simulation analysis","volume":"121","author":"Naughton","year":"2022","journal-title":"Biophys. J."},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0245","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0250","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1002\/bip.360221211","article-title":"Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features","volume":"22","author":"Kabsch","year":"1983","journal-title":"Biopolymers"},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0255","first-page":"8","article-title":"The PyMOL molecular graphics system","volume":"1","author":"Schr\u00f6dinger","year":"2015","journal-title":"Version"},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0260","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","article-title":"The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics","volume":"21","author":"Karran","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0265","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3233\/JAD-150696","article-title":"The anti-amyloid-\u03b2 monoclonal antibody 4G8 recognizes a generic sequence-independent epitope associated with \u03b1-Synuclein and islet amyloid polypeptide amyloid fibrils","volume":"50","author":"Hatami","year":"2016","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105433","article-title":"Immunoprecipitation of amyloid fibrils by the use of an antibody that recognizes a generic epitope common to amyloid fibrils","volume":"9","author":"Greiner","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0275","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2515673122","article-title":"Aducanumab binding to a\u03b2(1-42) fibrils alters dynamics of the N-terminal tail while preserving the fibril core","volume":"122","author":"Palani","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0280","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41587-019-0029-y","article-title":"Thousands of amyloids may foil Alzheimer\u2019s drugs","volume":"37","author":"Hodgson","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0285","article-title":"Structure and dynamics of lipid-stabilized amyloid beta A\u03b21\u201342 oligomers","author":"Al","year":"2025","journal-title":"Aggregates"},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0290","series-title":"Aggregation-Dependent Epitope Sequence and Modification Fingerprints of Anti-A\u03b2 Antibodies, bioRxiv","author":"Ivan","year":"2025"},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0295","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/prot.25978","article-title":"From monomer to fibril: Abeta-amyloid binding to Aducanumab antibody studied by molecular dynamics simulation","volume":"88","author":"Frost","year":"2020","journal-title":"Proteins"},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0300","article-title":"Perspectives on future Alzheimer therapies: amyloid-\u03b2 protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer\u2019s disease","volume":"6","author":"Lannfelt","year":"2014","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0305","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s13311-022-01308-6","article-title":"Lecanemab, Aducanumab, and Gantenerumab - binding profiles to different forms of amyloid-Beta might explain efficacy and side effects in clinical trials for Alzheimer\u2019s disease","volume":"20","author":"S\u00f6derberg","year":"2023","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ijbiomac.2026.150222_bb0310","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.neuron.2012.10.029","article-title":"A plaque-specific antibody clears existing \u03b2-amyloid plaques in Alzheimer\u2019s disease mice","volume":"76","author":"DeMattos","year":"2012","journal-title":"Neuron"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026001480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026001480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T01:56:06Z","timestamp":1769046966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026001480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":62,"alternative-id":["S0141813026001480"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.150222","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential conformational selections of three therapeutic antibodies binding to polymorphic A\u03b2 oligomers","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.150222","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150222"}}